Does this mean you are going to change the FDA warning?
FDA adds diabetes, memory loss warnings to statins - Reuters
But did your doctor account for this?
Taking statins raises the risk of Type 2 diabetes by nearly a third: Findings reopens debate about the pills benefits and side effects
The latest here:
Association between statin use and cognitive function: A systematic review of randomized clinical trials and observational studies
Researchers conducted the study for analyzing the connection between statin use and cognitive status in a population age ≥ 60. Twenty-four studies were included in the review. The sample consisted of 1,404,459 participants. No evidence of adverse cognitive effects, including dementia incidence, global cognition deterioration, or particular cognitive domains associated with statin use, has been identified in people aged 60 or older.
Read the full article on Journal of Clinical Lipidology.
No comments:
Post a Comment